Наука Просто
MedicineExplained7 min readSeptember 6, 2026

How a Drug Works in the Body When It Doesn't Know Where You Hurt

A pill does not search for the painful organ. After absorption, drug molecules circulate through the body, enter accessible tissues, interact with molecular targets, and are eventually metabolized and eliminated.

A pill dissolving inside the body as drug molecules enter the bloodstream, reach different tissues, and interact with a cellular molecular target

Illustration: Nauka Prosto, created with AI assistance.

To understand how a drug works in the body, start with an odd fact: a headache pill has no idea where your head is. It does not search for pain, receive coordinates from inflamed tissue, or choose a particular organ. Once taken, its molecules simply follow the chemistry and physiology of the body.

For an oral drug, the first challenge is getting inside. A tablet usually has to break apart and dissolve before its molecules can cross the gastrointestinal wall. Many drugs are absorbed mainly in the small intestine, whose enormous surface area is well suited for moving molecules into the circulation.

But swallowing a dose does not mean that the entire dose reaches the bloodstream. Some of the drug may never be absorbed. Some can be chemically transformed in the intestinal wall or liver before it enters the systemic circulation.

That is only the beginning of the journey.

Blood has no destination address

Once drug molecules reach the systemic circulation, blood carries them through the body. The heart does not direct them specifically toward an aching knee, the brain, or a tumor.

Distribution, however, is far from uniform.

Some molecules cross cell membranes easily. Others are restricted by their size, charge, or chemical properties. Some bind extensively to proteins in the blood. Different tissues receive different amounts of blood, and some organs are protected by specialized barriers.

The blood-brain barrier is the best-known example. Cells lining blood vessels in the brain form unusually tight interfaces and tightly regulate the passage of many substances into nervous tissue. A drug can circulate successfully through the bloodstream while reaching the brain only poorly.

Molecular transporters add another layer. These membrane proteins can help certain compounds cross biological barriers or pump them back out.

The concentration of the same drug can therefore differ substantially among blood, liver, muscle, fat, brain, and other tissues.

A drug acts where it can reach a target

Reaching a tissue is only half of the problem.

Most drugs produce their effects by interacting with specific molecular targets. A target may be a receptor, an enzyme, an ion channel, a transporter, or another molecule involved in cellular function.

The familiar lock-and-key analogy is oversimplified, but it captures an important principle: drugs do not act on an abstract entity called “disease.” They alter particular molecular processes.

If a tissue lacks the relevant target, the drug may pass through without producing the desired response. If the target is present but the drug cannot reach that tissue at an adequate concentration, the response may also be small.

Effective drug action therefore requires several conditions at once: sufficient exposure, access to the tissue, and a responsive molecular target.

A headache medicine does not travel toward the location of pain. Its molecules distribute through accessible parts of the body, and pain relief occurs because the drug changes biological processes involved in generating or transmitting pain.

This leads to two fundamental ideas in pharmacology.

Pharmacokinetics describes what the body does to a drug: absorption, distribution, metabolism, and elimination.

Pharmacodynamics describes what the drug does to the body once it reaches and interacts with its targets.

Neither side alone explains the full effect.

Why drugs act where we did not ask them to

The same logic explains many side effects.

A molecule cannot distinguish between an effect that a physician wants and one that is undesirable. If the same molecular target exists in several tissues, the drug may interact with it wherever sufficient concentrations are reached. At higher concentrations, some compounds can also interact with additional targets.

The properties that make systemic treatment possible can therefore also help produce unwanted effects.

Selectivity can improve this situation, but a “selective” drug is not necessarily physically confined to diseased tissue. More often, it means that the molecule interacts much more strongly with one target than with others, or that the target itself is enriched in particular cells.

Route of administration can also change exposure.

Eye drops place a drug close to the eye. A topical cream creates high local exposure in the skin. An inhaled medicine can deliver a large fraction of its dose directly to the respiratory tract. Injection can bypass gastrointestinal absorption altogether.

Even local delivery is rarely perfectly local, however. Some of the drug can still enter the systemic circulation.

The route of administration therefore changes the biological journey, not merely the convenience of taking a medicine.

The liver transforms drugs and the kidneys remove them

A drug does not remain in the body indefinitely.

The liver plays a major role in chemically modifying many foreign molecules. Metabolism can make a compound less active and easier to eliminate. In some cases metabolites remain pharmacologically active. Some medicines are even administered in a relatively inactive form and converted into an active compound after entering the body.

The kidneys provide another major route of elimination. They filter blood and remove many drugs and metabolites into urine. Other compounds may leave through bile and the intestine, while additional pathways matter for particular substances.

Drug concentration therefore changes with time. It rises as a compound is absorbed, reaches a certain exposure, and then falls as distribution, metabolism, and elimination proceed.

One useful concept is half-life: under defined conditions, the time required for the concentration of a drug to fall by about half. Depending on the drug, this can range from minutes to hours or days.

This is one reason doses sometimes have to be repeated. A previous tablet has not somehow “stopped knowing” where the pain is. The concentration of active drug has simply declined.

Why the same dose does not produce the same effect in everyone

Identical doses do not necessarily create identical drug concentrations in different people.

Absorption and distribution depend on the drug's chemical properties as well as factors such as food, age, body size, and body composition. Liver and kidney function influence metabolism and elimination. Genetic differences can alter enzymes and transporters. Other medicines can speed up or slow down some of these processes.

Two identical tablets therefore provide the same amount of drug at the starting line, but not necessarily the same concentration at the target — and not necessarily the same response.

Connecting dose, exposure, and effect is one of the central problems of clinical pharmacology.

Too little exposure may produce little benefit. As concentration rises, the desired effect may increase, but unwanted effects can rise as well. For many medicines, clinicians work within a range of doses and exposures where useful effects are expected while toxicity remains acceptably low.

Dose is therefore not just a number printed on a package. It is part of the drug's biological behavior.

A pill truly does not know where you hurt. It does not need to.

The body defines the route: the gut determines absorption, blood distributes the molecules, membranes and biological barriers determine access, molecular targets determine effects, and the liver and kidneys help determine how long the compound remains.

A medicine works because two processes meet: where the body allows the molecule to go and what that molecule can do when it gets there.